Executive Compensation

Performance-Based Equity Award Trends in Public Companies

Lexis Practice Advisor® Practice Note by James F. Reda, Arthur J. Gallagher & Co.

Learn more about trends and emerging practices in the granting of performance-based equity awards by public companies. James Reda discusses factors that have contributed to these trends and the prevalence of certain plan design characteristics, including insights gained through the examination of survey data on plan design among mid-market companies. Further, he predicts the effect of recent tax reform on future performance-based compensation. See a pdf of the article here.

This excerpt from Lexis Practice Advisor®, a comprehensive practical guidance resource providing insight from leading practitioners, is reproduced with the permission of LexisNexis. Reproduction of this material, in any form, is specifically prohibited without written consent from LexisNexis.

The Biotechnology Sector: Key Executive Compensation and Corporate Governance Trends

Journal of Compensation and Benefits March/April 2019

Author James Reda, practice leader of Gallagher’s Executive Compensation service line, examines executive compensation trends among companies in the biotechnology sector, which has exploded in recent decades. Topics include the use of performance milestones for both short- and long-term incentive programs. See a pdf of the article here.